Unichem Laboratories Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is TOPIRAMATE USP, with a corresponding US DMF Number 35191.
Remarkably, this DMF maintains an Active status since its submission on September 28, 2020, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 24, 2020, and payment made on September 18, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II